NIH-funded research Fellowship grant

Understanding how cocaine affects brain signaling related to addiction

Official title: Elucidating the Mechanisms and Relevance of Cocaine-Induced Plasticity of Inhibitory G Protein Signaling in the Prelimbic Cortex

Funded at University of Minnesota · NIH-11066729 · Data updated 2026-11-12

This study is looking at how cocaine affects certain brain cells related to addiction in mice, with the hope of finding new ways to help people recover from cocaine use.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startJune 1, 2025
Project endMay 31, 2028
Funding year2025
Award (this year)$46,478
NIH project number1F31DA062412-01
Project IDNIH-11066729 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals struggling with cocaine addiction or those at risk of developing such an addiction.

Less likely to help

Patients who do not use cocaine or have no history of substance abuse may not benefit from this research.

What this research studies

This research investigates how cocaine alters the signaling pathways in specific brain cells that are involved in addiction. By studying the effects of cocaine on inhibitory G protein signaling in the prelimbic cortex of mice, the researchers aim to uncover the cellular and neurochemical changes that occur with repeated drug exposure. The approach involves genetic manipulation and behavioral assessments to understand how these changes contribute to addiction. The ultimate goal is to explore potential therapeutic strategies that could restore normal signaling in the brain affected by cocaine use.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for cocaine addiction by restoring normal brain signaling pathways.

How similar studies have gone: Previous research has shown promising results in understanding the neurobiological mechanisms of addiction, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Welter, Alex Larsen — University of Minnesota
  • Study coordinator: Welter, Alex Larsen

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.